In the absence of any material event concerning Ottobock SE & Co KGaA today, the company’s standing in the market remains unchanged.

  • Market position: Ottobock’s shares trade at €60.85 as of 5 February 2026, comfortably below the 52‑week low of €60.10 and still distant from the recent peak of €76.35 reached on 25 November 2025.
  • Valuation: With a price‑to‑earnings ratio of 7.03, the stock is relatively cheap compared with typical health‑care peers, signalling room for upside should the firm’s earnings improve.
  • Capitalisation: The company’s market cap sits at €3.89 billion, a modest figure in the broader German equity universe, yet sufficient to support a stable investor base.

Although the wider German tech indices (TecDAX and SDAX) saw modest movements on 9 February 2026, Ottobock’s fundamentals remain the sole focus of this brief. No earnings releases, mergers, or regulatory developments entered the news feed for the day, leaving the company’s trajectory unchanged.